therapeutictouch

What is Therapeutic Touch?


Therapeutic touch (TT) was developed by Delores Krieger, R.N., Ph.D., and Dora Kunz, a natural healer, in the early 1970s. Therapeutic touch is a modern adaptation of several religious and secular healing traditions and is most commonly used in nursing practice for a wide range of health conditions.

Read more on www.intelihealth.com
Also known as Reiki, Laying-on-of-Hands
Search for any health
topic on HealthMash:

Explore and Discover

Tests and Treatments
Drugs and Substances
» natural

Therapeutic Touch information from trusted sources:

Carotid artery surgery

Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, et al. Carotid endarterectomy -- an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005,65:794–801.

Read more on www.nlm.nih.gov

Therapeutic touch - Wikipedia, the free encyclopedia

Therapeutic touch (commonly shortened to "TT"), also called Non-Contact Therapeutic Touch (NCTT), "Healing Touch," or Distance Healing, is an energy therapy ...

Read more on en.wikipedia.org

Why Therapeutic Touch Should Be Considered Quackery

by S Barrett - Related articles

Read more on scholar.google.com

Therapeutic Touch

Therapeutic Touch (TT) is a technique in which the hands are used to direct human energy for healing purposes.

Read more on www.cancer.org

Therapeutic Touch: Further Notes

Therapeutic Touch was developed in the early 1970s by Dolores Krieger RN, a professor of nursing. Krieger and co-founder Dora Kunz stated that the human ...

Read more on www.quackwatch.com

Therapeutic Touch - definition of Therapeutic Touch in the Medical ...

Therapeutic touch, or TT, is a noninvasive method of healing that was derived from an ancient laying—on of hands technique. In TT, the practitioner alters ...

THERAPEUTIC GEL

Treats itchy skin caused by psoriasis, seborrhea, dandruff, or other conditions. Some forms of this medicine treat scaling and dry skin, which may cause itching.

Read more on www.pdrhealth.com

TDM

Therapeutic drug monitoring is the measurement of specific drugs at intervals in order to maintain a relatively constant concentration of the medication in the bloodstream. Drugs that are monitored tend to have a narrow therapeutic range &ndash, the quantity required to be effective is not far removed from the quantity that causes significant side effects and/or signs of toxicity. Maintaining this steady state is not as simple as giving a standard dose of medication. Each person will absorb, metabolize, utilize, and eliminate drugs at a different rate based upon their age, general state of health, genetic makeup, and the interference of other medications that they are taking. This rate may change over time and vary from day to day.

Read more on www.labtestsonline.org

Therapeutic endoscopy of the stomach

An endoscopy is a procedure where the inside of your body is examined using an endoscope. An endoscope is a long, thin, flexible tube with a camera and light inside. It sends images of the inside of your body to a monitor (screen).

Read more on www.nhs.uk

Estradot Transdermal Therapeutic System

Estrogens are female hormones. They are produced by the body and are necessary for the normal sexual development of the female and for the regulation of the menstrual cycle during the childbearing years.

Read more on www.mayoclinic.com

Contents

Reiki
The practice of Reiki, which may be as old as 2,500 years, is mentioned in Tibetan sutras and in ancient records of cosmology and philosophy. The name Reiki comes from the Japanese words rei, meaning "universal spirit," and ki, meaning "life energy." The Japanese physician and Buddhist monk Hichau Mikao Usui revitalized the practice of Reiki in the 19th century. Hawayo Tokata introduced Usui Reiki to the West in the 1930s.

Read more on www.intelihealth.com
Sirolimus
Clinical Therapeutics, Volume 22, Supplement B, April 2000 [see Dosage and Administration (2.3) ].

Read more on www.druglib.com
Pamine
Gilman A, Gilman AB, Goodman LA, eds. The Pharmacological Basis of Therapeutics.6th ed. New York: MacMillan Publishing Company.1980. American Hospital Formulary Service. American Society of Hospital Pharmacists. Bethesda, Maryland. Domino EF, Corasen G. Central and Peripheral Effects of Muscarinic Cholinergic Blocking Agents in Man. Anesthesiology 1967,28:568-574. Mogensen L, Orinius E. Arrhythmic Complications after Parasympathetic Treatment of Bradyarrhythmias in a Coronary Care Unit. Acta...

Read more on www.druglib.com
Dacarbazine
Loo, T.J., et al.: Mechanism of action and pharmacology studies with DTIC (NSC-45388). Cancer Treatment Reports 60: 149-152, 1976. Nathanson, L., et al.: Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma. Clinical Pharmacology and Therapeutics 12: 955-962, 1971. Costanza, M.E., et al.: Therapy of malignant melanoma with an imidazole carboxamide and bischloroethyl nitrosourea. Cancer 30: 1457-1461, 1972. Luce, J.K., et al.: Clinical trials with the antitumor...

Read more on www.druglib.com
Versenate
Thomas DJ, Chisolm JJ. Lead, zinc and copper decorporation during calcium disodium ethylenediamine tetraacetate treatment of lead-poisoned children. J Pharmacol Exp Therapeu 1986, 239: 829-835. The Pharmacological Basis of Therapeutics, 7th edition, Goodman and Gilman, editors. MacMillan Publishing Company, New York, 1985, pp. 1619-1622. Hammond PB, Aronson AL, Olson WC. The mechanism of mobilization of lead by ethylenediaminetetraacetate. J Pharmacol Exp Therapeu 1967, 157: 196-206. Van deVyver...

Read more on www.druglib.com
Lipofen
GOLDBERG AC, et al. Fenofibrate for the treatment of Type IV and V Hyperlipoproteinemias: A Double-Blind, Placebo-Controlled Multicenter US Study. Clinical Therapeutics, 11, pp. 69-83, 1989. NIKKILA EA. Familial Lipoprotein Lipase Deficiency and Related Disorders of Chylomicron Metabolism. In Stanbury J.B., et al. (eds.):The Metabolic Basis of Inherited Disease, 5th edition, McGraw-Hill. 1983, Chap. 30, pp. 622-642. BROWN WV, et al. Effects of Fenofibrate on Plasma Lipids: Double-Blind, Multicenter...

Read more on www.druglib.com
Cervidil
Physiology of Labor In: Williams Obstetrics. Eds. Pritchard, J. A., MacDonald, P. C., and Gant, N.F. Appleton-Century-Crofts, Conn, Pp 295-321, (1985). Rall, T. W. and Schliefer, L. S. Oxytocin, prostaglandin, ergot alkaloids, and other drugs, tocolytics agents, In: The Pharmacological Basis of Therapeutics. Eds. Gilman, A.G., Goodman, L.S., Rall, T.W., and Murad, F. MacMillan, Publ. Co., New York, Pp. 926-945, (1985). Casey, M.L. and MacDonald, P.C. The initiation of labor in women: Regulation...

Read more on www.druglib.com
Triglide
Goldberg AC, et al. Fenofibrate for the Treatment of Type IV and V Hyperlipoproteinemias: A Double-Blind, Placebo-Controlled Multicenter US Study. Clinical Therapeutics 1989, 11: 69-83.Nikkila EA. Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In: Stanbury JB, ed. The metabolic basis of inherited disease: McGraw-Hill, 1983, 622-642.Brown WV, et al. Effects of Fenofibrate on Plasma Lipids: Double-Blind, Multicenter Study in Patients with Type IIA or IIB...

Read more on www.druglib.com
Tricor
GOLDBERG AC, et al. Fenofibrate for the Treatment of Type IV and V Hyperlipoproteinemias: A Double-Blind, Placebo-Controlled Multicenter US Study. Clinical Therapeutics, 11, pp. 69-83, 1989. NIKKILA EA. Familial Lipoprotein Lipase Deficiency and Related Disorders of Chylomicron Metabolism. In Stanbury J.B., et al. (eds.): The Metabolic Basis of Inherited Disease, 5th edition, McGraw-Hill, 1983, Chap. 30, pp. 622-642. BROWN WV, et al. Effects of Fenofibrate on Plasma Lipids: Double-Blind, Multicenter...

Read more on www.druglib.com
Lofibra
GOLDBERG AC, et al. Fenofibrate for the Treatment of Type IV and V Hyperlipoproteinemias: A Double-Blind, Placebo-Controlled Multicenter US Study. Clinical Therapeutics, 11, pp. 69-83, 1989. NIKKILA EA. Familial Lipoprotein Lipase Deficiency and Related Disorders of Chylomicron Metabolism. In Stanbury J.B., et al. (eds.): The Metabolic Basis of Inherited Disease, 5th edition, McGraw-Hill, 1983, Chap. 30, pp. 622-642. BROWN WV, et al. Effects of Fenofibrate on Plasma Lipids: Double-Blind, Multicenter...

Read more on www.druglib.com
Pyrazinamide
Drug Information, American Hospital Formulary Service. American Society of Hospital Pharmacists. Bethesda, Md. 1991. USPDI, Drug Information for the Health Care Professional. United States Pharmacopeial Convention, Inc. Rockville, Md. 1991: 1 B: 2226-2227. Goodman-Gilman A, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics, ed 8. New York, Pergamon Press. 1990, 1154. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis. 1986, 134:...

Read more on www.druglib.com